The Prognostic Value of Extracellular Matrix Component Concentrations in Serum During Treatment of Adult Respiratory Distress Syndrome with Extracorporeal CO2 Removal
Open Access
- 1 January 1991
- journal article
- research article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 29 (12), 805-12
- https://doi.org/10.1515/cclm.1991.29.12.805
Abstract
The time-dependent concentrations of hyaluronan, aminoterminal propeptide of type III procollagen, and laminin were determined in sera of 16 patients with severe adult respiratory distress syndrome during treatment with an extracorporeal CO2 removal device. Patients were classified according to lung parameters as responders (n = 10) and non-responders (n = 6) to extracorporeal CO2 removal. At the beginning of treatment strongly elevated serum concentrations of all studied extracellular matrix components were found. During the first 6-11 days of treatment the concentrations of aminoterminal propeptide of type III procollagen and hyaluronan increased further in non-responders but decreased in the majority of responders, while laminin decreased in both groups. No significant correlations were found between the serum concentrations of connective tissue components and the parameters of lung function. By non-parametric analysis of variance, significant differences between responders and non-responders according to treatment time could be established. By analysing the time course of the serum concentrations of hyaluronan and aminoterminal propeptide of type III procollagen, a total differentiation between responders and nonresponders was made possible by the trends of these analytes as early as three days after the start of treatment. The determination of aminoterminal propeptide of type III procollagen and hyaluronan in serum of patients with adult respiratory distress syndrome might therefore have prognostic significance in extracorporeal CO2 removal.Keywords
This publication has 20 references indexed in Scilit:
- Unsere Erfahrungen mit der extrakorporalen CO2-Elimination bei Patienten mit schwerem ARDS - eine aktuelle ÜbersichtAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 1989
- The adult respiratory distress syndromeKlinische Wochenschrift, 1989
- Accumulation of Hyaluronan (Hyaluronic Acid) in the Lung in Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1989
- Extrakorporale CO2-Elimination: Ein neues Konzept zur Behandlung des schweren ARDSDeutsche Medizinische Wochenschrift (1946), 1989
- Serum laminin and procollagen type III propeptide in patients with respiratory distress syndrome: Potentially useful markers of therapy successAnalytical and Bioanalytical Chemistry, 1988
- Increased Serum Levels of Hyaluronate in Liver DiseaseHepatology, 1985
- A New Look at Therapy of the Adult Respiratory Distress SyndromeInternational Anesthesiology Clinics, 1983
- Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease.Thorax, 1981
- TREATMENT OF ACUTE RESPIRATORY FAILURE WITH LOW-FREQUENCY POSITIVE-PRESSURE VENTILATION AND EXTRACORPOREAL REMOVAL OF CO2The Lancet, 1980
- Bedside measurement of lung waterJournal of Surgical Research, 1979